A comparative study of platelet-rich plasma, hydroxyapatite, demineralized bone matrix and autologous bone to promote bone regeneration after mandibular impacted third molar extraction. by Arenaz Búa, Jorge et al.
Med Oral Patol Oral Cir Bucal. 2010 May 1;15 (3):e483-9.                                                                               Use of platelet-rich plasma  and other biomaterials in mandibular bone regeneration 
E483
Journal section: Oral Surgery                                                                                                                                         doi:10.4317/medoral.15.e483
Publication Types: Research
A comparative study of platelet-rich plasma, hydroxyapatite, demineralized 
bone matrix and autologous bone to promote bone regeneration after mandi-
bular impacted third molar extraction
 
Jorge Arenaz-Búa 1, Ramón Luaces-Rey 2, Sheila Sironvalle-Soliva 1, Beatriz Patiño-Seijas 2, Álvaro García-
Rozado 2, Roberto Martín-Sastre 2, José Ferreras-Granados 2, Fernanda Lorenzo-Franco 2, Inés Vázquez-
Mahía 2, José-Luis López-Cedrún 3
1 Resident. Department of Oral and Maxillofacial Surgery, Complejo Hospitalario Universitario de A Coruña 
2 Staff. Department of Oral and Maxillofacial Surgery, Complejo Hospitalario Universitario de A Coruña 
3 Head of Department Department of Oral and Maxillofacial Surgery, Complejo Hospitalario Universitario de A Coruña
Correspondence: 
Travesía de Cordelería Nº1 4º Izq
15003 La Coruña (La Coruña), Spain
jorgearenaz@gmail.com 
Received: 25/02/2009
Accepted: 12/09/2009
Abstract
Objectives: 1) to compare mandibular bone regeneration by applying autologous bone, platelet-rich plasma and 
two biomaterials (synthetic calcium hydroxyapatite, and demineralized bone matrix), and thus establish the poten-
tial benefits of these biomaterials in the regeneration of postextraction alveolar bone, 2) to identify wich of them 
accelerates more bone regeneration and 3) to determine whether there are differences in the postoperative period 
(pain, swelling, trismus, infection) depending on the material used.
Study Design: It consists in a prospective, controlled (with a split- mouth design) and double blinded study. We use 
as a model an easily reproducible non-critical bone defect: the defect that remains after extraction of mandibular 
impacted third molar. The study design is based on the extraction of two mandibular impacted third molars in 
a patient during the same surgical procedure by the same surgeon. We assessed postoperative clinical data, and 
short, medium and long term neoformation of alveolar bone after extraction. We compared the two sockets (right 
and left), which had been grafted in a different way with the various elements mentioned above. In addition, we 
compared the postoperative inflammatory symptoms between groups. 
Results: The highest acceleration in bone formation was observed in groups in which we used autologous bone 
and demineralized bone matrix. There were no statistically significant differences between groups regarding pain, 
swelling, trismus and infection throughout the postoperative period. 
Conclusions: According to the results of our study, autologous bone persists as the gold standard material for bone 
regeneration. Among the assessed biomaterials, demineralized bone matrix has yielded the best results obtained. 
No significant differences in the postoperative (pain, swelling, trismus and infectious events) were observed, de-
pending on the type of material used as a graft. 
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Introduction 
The study of materials to promote bone regeneration 
is a key issue in oral surgery. The autologous bone is 
still considered as the gold standard (1-10). Autologous 
bone grafts have a number of advantages such as their 
potential osteogenic, osteoinductive and osteoconduc-
tor properties, the absence of rejection and disease 
transmission. Furthermore, autologous bone grafts do 
not require sophisticated and expensive techniques to 
obtain them (6). However a number of disadvantages 
were described: morbidity in the donor site, the need for 
general anesthesia or sedation, as well as the occasional 
need for more than one surgical field. In addition, graft 
survival is unpredictable, its resorption cannot be fore-
told and availability is limited (6). 
It is for the reason that in recent years several biocom-
patible materials have emerged as substitutes of  au-
tologous bone. These can be classified into two major 
groups: organic and synthetic. Biological biomateri-
als can be allogeneic or homologous (human cortical 
bone and demineralised bone matrix or demineralized 
freeze-dried), heterologous, or xenogeneic (organic bo-
vine, porcine, caprine, coral-derived hydroxyapatite) 
and replicating (morphogenetic proteins). Among syn-
thetic biomaterials we can find artificial or synthetic hy-
droxyapatite, the bioglass and bioceramics (6). 
In addition, over the last 20 years a large number of 
publications advocating the use of  platelet-rich plasma 
(PRP) in oral surgery have been published. There is 
evidence and consensus on its utility in the regenera-
tion of soft and periodontal tissues (1-4, 11-13). On the 
other hand, there are plenty of publications that show 
that there is not enough scientific evidence to support 
the use of PRP in accelerating bone healing. 
Therefore there are many biomaterials available for the 
oral surgeon s´ use to promote bone healing. But the ex-
act indication of each of them remains controversial. 
There is no therapeutic consensus algorithm, and there 
are few clinical trials with sufficient statistical power 
(6,14). 
Our hypothesis is that the PRP and other biomaterials 
such as calcium hidroxipatita synthetic and demineral-
ized bone matrix can replace autologous grafts in pro-
moting bone regeneration in mandibular bone defects.
Objectives 
To determine the role and usefulness of the PRP and 
other biomaterials (synthetic calcium hydroxyapatite 
and allogenic, demineralized bone matrix) in mandibu-
lar bone regeneration compared with autologous bone 
(gold standard). We use as a model an easily reproduc-
ible non-critical bone defect: the defect that remains af-
ter extraction of mandibular impacted third molar.
Therefore, the aim of this study was to try to answer the 
following questions: 
• Are there differences in the rate of bone formation 
in the  postextraction socket among those grafted with 
PRP and controls (not grafted)? 
• Are there differences in  the neoformation of bone be-
tween the two different procedures to obtain platelet-
rich plasma (PRP)? 
• Which biomaterial accelerates more bone regeneration 
in non-critical mandibular bone defect ? 
• Are there significant differences between them with 
each other and with respect to autologous bone in the 
acceleration of bone neoformation? 
• Are there differences in the clinical inflammatory and 
postoperative (postoperative pain, intraoral-extraoral 
swelling, trismus) and infectious events observed de-
pending on the material used to graft the socket? 
Material and Methods 
The study was carried out between the years 2003 and 
2006 in the Department of Oral and Maxillofacial Sur-
gery of the Complejo Universitario de A Coruña. This is 
a prospective, randomized, controlled (through a split-
mouth desing), and double blinded study. This study 
was approved by the bioethics committee of the Juan 
Canalejo Hospital on January 25th 2003 and has been 
subsidized by the General Directorate of R & D of the 
Xunta de Galicia and the Galician Health Service (2005, 
code PGIDIT 5SAN59PR). 
Inclusion criteria. To carry out this study we selected 82 
patients with bilateral impacted mandibular third molars, 
ftaking into account the following inclusion criteria: 
• Aged between 18 and 50 years old. 
• Impacted mandibular third molar  3.8. and 4.8, with 
a similar anatomical position, and similar surgical dif-
ficulty. 
• The patient signed the informed consent  to carry out 
the intervention and for inclusion in the study. 
• No allergies to medicines prescribed in the postopera-
tive period.
• To follow the same postoperative treatment: Amoxi-
cillin 500 mg every 8 hours during 7 days, deflazacort 
30 mg every 12 hours for 5 days and metamizol 575 mg 
every 8 hours to demand. 
Study groups. The patients were divided into 5 groups 
(Table 1). In two groups (groups 1 and 2) we compared 
the control socket (no biomaterial) with the study socket 
(platelet-rich plasma). These two groups differ in the 
methodology used in obtaining the PRP (methods 1 and 2 
respectively ). In groups 3, 4 and 5, we administered PRP 
obtained by the same method (Method 1) on the control 
side, compared with the study side in which we adminis-
tered a combination of PRP with another product: 
• Autologous bone obtained from aspiration and filter-
ing during the osteotomy (group 3). 
• A synthetic material based on synthetic calcium hy-
droxyapatite (Novabone ® Porex Surgical Inc, MTF, 
USA) (group 4). 
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• Allogeneic demineralized bone matrix (DBX ®, Syn-
thes, USA) (group 5). 
Surgery. Extractions of both mandibular third molars 
was performed under local anesthesia. All extractions 
were performed by the same surgeon. Both post-extrac-
tion sockets were grafted with different biomaterials, 
according to the distribution of the study groups (Fig. 
1). All patients received the same antibiotic, anti-in-
flammatory and analgesic postoperative treatment. 
Monitoring and variables. (Fig. 2). The studied pre-
Table 1. Study groups. (“PRP Method 1” and “PRP Method 2”: platelet-rich plasma obtained by two different procedures, respectively 
called 1 and 2 "ANY MATERIAL": there is no material in the postextraction socket). 
Fig. 1. Group 3: a mixture of autologous bone collected by filtration during the ostectomy and platelet-rich plasma is obtained (A) 
and applied in the postextraction socket (B). Note that PRP facilitates the manipulation of the particulate bone graft. The rest of the 
platelet-rich plasma obtained by the same method as above (C) is applied alone in the socket of the control side (D). 
CONTROL SOCKET STUDY SOCKET FREQUENCY PERCENTAGE
GROUP 1 ANY MATERIAL PRP METHOD 1 19 23,2%
GROUP 2 ANY MATERIAL PRP  METHOD 2 15 18,3%
GROUP 3 PRP METHOD 1 AUTOLOGOUS BONE + PRP 1 19 23,2%
GROUP 4 PRP METHOD 1 PRP METHOD 1+NOVABONE R 15 18,3%
GROUP 5 PRP METHOD 1 PRP METHOD 1+ DBX R 14 17,1%
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dictor variables were age, sex of the patient, difficulty 
of intervention (easy, intermediate or high difficulty, 
assessed in terms of surgical time by an experienced 
surgeon), and type of material used in the filling of the 
postextraction socket. 
We assessed several response variables on the postopera-
tive evolution in two ways. On the one hand, through a 
clinical questionnaire that each patient completed daily 
throughout the first postoperative week. This question-
naire asssesed pain (using two methods: an analog pain 
scale from 1 to 10 points, and the number of analgesics to 
control pain consumed on each of the first 7 postoperative 
days) as well as the number of days that passed until the 
restart of a normal diet. On the other hand, a single clinical 
observer performed a clinical assessment in the 7th post-
operative day. This observer assessed the most inflamed 
side, decreased mouth opening measured in mm compared 
to that observed at the time of the intervention, and the oc-
currence of infectious events. This clinical observer was 
blinded for whether or not socket grafting was performed, 
and the type of grafted material. In this appointment, the 
questionnaire mentioned above was collected. 
In addition we compared the bone formation on both 
sides using digital panoramic obtained in the immedi-
ate postoperative period, at the 3 and in 6 months after 
the surgery. The measurement of bone neoformation 
was performed subjectively but blindly, recording the 
score in a radiopaque increasing scale (1, minimal or 
radiopaque bone formation 5, maximum or radiopaque 
bone formation) by 4 blinded observers, who were staff 
surgeons of the research team. A process of calibration 
between the different observers took place before to 
assess the degree of concordance. The observers were 
blinded as to the type of material used for grafting the 
postextraction socket. Although this material is partial-
ly radiopaque (such as calcium hydroxyapatite), this ra-
diopacity is not considered formed bone. For an expert 
observer (as the ones in the study) it is not difficult to 
differentiate between the neoformation of bone and the 
radiopacity produced by the existence of a biomaterial. 
In addition, due to resorption of the grafted material, 
there is no possibility of bias in the assessment at 6 and 
3 months. CT and bone biopsy were excluded for eco-
nomic and ethical reasons. 
Fig. 2. Schematic summary of material and methods. (PRP: platelet-rich plasma, G1, G2, G3, G4, G5: groups 1, 2, 3, 4 and 5 respectively; DBX: 
demineralized bone matrix; OPG: orthopantomography). 
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The data obtained were statistically analyzed with the 
SPSS 16.0 for Windows (SPSSS Inc. 2006). 
Platelet-rich plasma. PRP was obtained  in two differ-
ent services of Hematology: the Hematology Service 
of the Hospital Universitario de A Coruña (Method 1), 
and the Hematology Service of the Hospital “Arquitecto 
Marcide” Ferrol (method 2). Both methods use a double-
spin system, but with different parameters and different 
methods for extracting the supernatant (using a laminar 
flow hood and another by pipetting). 
Results 
Of the 82 patients included in the study 37 were males 
and 45 were females. The median age of patients in our 
study is 23 years, with a minimum of 18 years and max-
imum of 45 years (mean: 24.16; typical dev: 5.76). 
The distribution of study groups according to the mate-
rial used is as shown in (Table 1). We observed a greater 
degree of surgical difficulty in the extraction in group 3 
(autologous bone) and 5 (DBX® ) on the control side as 
well as on the study side. In what refers to the pain re-
corded by patients on the pain analogue scale from 1 to 
10, we observed more pain on the study side, although 
no significant differences between groups were found. 
However, it an increased use of analgesics in groups 1, 2 
and 3 (PRP and bone) compared to groups 4 and 5 (No-
vabone® and DBX®) with no statistically significant 
differences between groups was observed. The study 
groups with more days of dysphagia were 4 and 3 (No-
vabone® and bone). 
Concerning the clinical variables observed on the 7th 
postoperative day by a blinded clinical observer, we can 
say that in most cases, both the control and study sides 
were equally swollen, although there is a greater ten-
dency to inflammation in the study side. There were no 
statistically significant differences between the studied 
groups. There is also no statistically significant differ-
ences in the incidence of infectious events among the 
study side and the control side. Intraoral inflammation 
observed on the 7th postoperative day was higher in 
group 3 (bone) and 5 (DBX®), although both groups 
have the greater surgical difficulty, wich could cause a 
bias. On 7th postoperative day, the greatest percentage 
of patients with extraoral inflammation belong to group 
3 (bone) and 2 (PRP 2). We considered trismus as an 
oral opening less than 35 mm. The greater percentage of 
patients with trismus on 7th  postoperative day was ob-
served in the gropus 3 (bone) and 4 (Novabone®). The 
groups with less patient with trismus were the groups 5 
(DBX®) and 1 (PRP method 1). 
In what regards bone formation, bone gain observed at 
3rd postoperative month compared to the immediate 
postoperative period was higher in groups 1, 2 and 3 
(PRP and autologous bone) and lower in groups 4 and 5 
(DBX® and Novabone® ). Bone formation observed at 
6th postoperative month, with respect to 3rd postopera-
tive month is higher in groups 3 (autologous bone) and 5 
(DBX® ) (p=0,049). The lowest increment was found in 
groups Novabone® and PRP groups. There is a progres-
sive ossification of the surgical site in all study groups 
except Novabone® (p=0.0045). The greatest bone for-
mation at 6th postoperative month is observed in group 
3 (autologous bone), followed by group 5 (DBX ®). The 
greatest bone gain at 6 months compared to the imme-
diate postoperative period was observed in group 3 (au-
tologous bone) followed by group 5 (DBX ®) (Fig. 3).
Fig. 3. Schematic summary of results. A diagram shows the median 
score in the study socket on each moment of follow up. The greater 
bone formation at 6 months was observed in the group of autologous 
bone (group 3) followed by  DBX ® (group 5). 
Discussion 
The platelet-rich plasma (PRP) is defined as a high con-
centration of autologous platelets in a small volume of 
autologous plasma (1,2). These intact platelets contained 
in this concentrate of autologous plasma would release 
their alpha granules in the first minutes after their ac-
tivation. These alpha granules contain molecules such 
as PDGF, TGFB, IGF, and other angiogenic factors that 
stimulate proliferation, chemotaxis and differentiation 
of cells essential to osteogenesis. These molecules could 
accelerate a process that occurs by itself (it does not cre-
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ate a new process). Throughout the past 20 years, PRP 
has been widely used in many medical applications (to 
speed up the healing process of burns, chronic ulcers, in 
the repair knee ligaments, as an hemostatic, to promote 
retinal neurogenesis, etc.). There are many  randomized 
clinical trials that have established PRP usefulness in 
the field of soft tissue regeneration. The first article that 
quotes the use of PRP in oral surgery was published in 
1997 by Whitman et al. (3) It states that through the acti-
vation of platelets in the platelet gel, and the subsequent 
release of growth factors, we could expect the accelera-
tion of surgical wound healing (3). Perhaps the most out-
standing paper in what refers to platelet-rich plasma in 
the field of oral and maxillofacial surgery was published 
by Marx in 1998 (4), who performed 88 autologous bone 
grafts in human jaws, to half of which these authors 
added PRP. Marx et al. (4) gathered both radiographic 
and histomorphometric studies showed greater matura-
tion and bone density, statistically significant compared 
to the control group. There are several publications for 
the use of PRP in oral surgery. There is evidence and 
consensus on its utility in the regeneration of soft tissue 
and periodontal defects (1-4, 11,12,14). On the contrary 
there are also plenty of publications that show that now-
adays there is not enough scientific evidence to support 
the use of PRP in accelerating bone healing, and insist 
that the oral surgeon must take a critical and analytical 
attitude (5-10, 15) Esposito et al. (6) in a meta-analysis 
published in 2006 state that there is no reliable evidence 
to support the effectiveness of any active molecules 
such as platelet-rich plasma as promoters of bone for-
mation in the treatment of dental implants. Boyapati et 
al. (7) concluded in his review article of June 2006 “at 
present, because of limited scientific evidence, the ad-
junctive use of PRP in sinus augmentation cannot be 
recommended”. Sanchez et al. (10) indicate that there is 
a clear lack of scientific evidence to support the use of 
PRP in combination with other graft bone augmentation 
procedures, even if the grafted material is autologous 
bone. Besides emphasizing the need for well designed, 
controlled and randomized studies, before recommend-
ing this procedure routinely. Recently, Plachokova et 
al. (8) found evidence of beneficial effects of PRP in 
the treatment of periodontal defects but the evidence of 
beneficial effects in sinus lift seems to be weak. They 
concluded that considering the literature review in their 
article conclusions about other applications of PRP in 
dentistry cannot be drawn. 
In our study we didn’t observe further acceleration in 
bone formation at 6 months, either in cases in which PRP 
was used alone nor in those cases where PRP was mixed 
with autologous bone or other biomaterials. We didn’t 
find differences between the two different methods of 
obtaining PRP. Like Thor et al. (9) we found that PRP 
facilitates and accelerates bone formation in the begin-
ning of the bone healing (the three first months in the 
postoperative period). This effect is not already observed 
at the 6th month. So like other authors, we can not sup-
port the indication of the use of PRP in this type of bone 
defect because there is no acceleration of bone healing. 
We agree with other authors that there is a better healing 
of soft tissue and increased handling of the graft. 
Demineralised bone matrix (DBX®, Synthes, USA) 
is a suitable substitute for cancellous bone. It presents 
osteoinductive and osteoconductive properties. These 
properties are known experimentally since the work 
of Urist in the 70s (16-19). DBX consists in demineral-
ised bone to which an organic carrier is added (sodium 
hyaluronate). It is extracted from human cortical bone, 
by removing the mineral phase and preserving the col-
lagen and morphogenetic proteins (BMPs). Removing 
the mineral phase enhances the bioavailability of these 
morphogenetic proteins, which would promote the bone 
neoformation (17). There is a lot of literature support-
ing its use as an accelerator of the bone healing. This 
biomaterial presents multiple applications in oral and 
craniomaxillofacial surgery (16-19) . We have noticed 
that demineralised bone matrix accelerates significantly 
bone formation in the studied defect. 
Synthetic calcium hydroxyapatite (Novabone gran-
ules, Porex Surgical, Inc, MTF, USA) is a synthetic, 
particulate and inorganic bone. It is biocompatible and 
resorbable in 6 months (bioglass) and it also presents 
osteoconductive activity (13,20). We have not observed 
any benefit in its use to accelerate bone formation in the 
post-extraction socket. 
Conclusions 
The faster bone formation occurred in the groups where 
we used autologous bone and demineralized bone ma-
trix, respectively. Autologous bone remains as the gold 
standard of materials used to optimize the mandibular 
bone regeneration. Among the biomaterials compared 
in the study, demineralized bone matrix is the second 
most effective in bone neoformation. 
We have not observed in our study that the platelet-rich 
plasma accelerates bone formation in post-extraction 
sockets. Platelet-rich plasma mixed with other bioma-
terials facilitates the manipulation of the graft (made 
of hydroxyapatite, for example) and therefore could be 
useful as a biological carrier in mandibular bone recon-
struction due to its low cost and ready availability. 
There were no statistically significant differences be-
tween groups in postoperative follow up. Finally, it is 
important to emphasize the difficulty observed in se-
lecting an appropriate method to objectively quantify 
bone formation. Further studies, with larger number of 
cases and controls, are necessaries to assess bone neo-
formation with biomaterials used in this study (as well 
as other biomaterials) to establish conclusive results.
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